Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Madagascar Health Press.
Press releases published on September 9, 2025

Actuate Therapeutics Announces Proposed Public Offering of Common Stock
CHICAGO and FORT WORTH, Texas, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult …

Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance
MOUNTAIN VIEW, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …

OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar’s Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing WALTHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- OptimizeRx (the “Company”) …

InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2025
DENVER, Sept. 09, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All- …

Picard Medical, Inc. Announces Exercise of Underwriters’ Over-Allotment Option in Connection with its Initial Public Offering
TUCSON, Ariz., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that the underwriters of its previously announced initial public offering of common stock, par value $0.0001 per share …

Celcuity Announces Upsized Senior Secured Term Loan Facility of $500 Million with Innovatus Capital Partners and Oxford Finance
MINNEAPOLIS, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (“Celcuity”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it has entered into an amendment to its existing senior secured …

CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025
ZUG, Switzerland and BOSTON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that a late-breaking oral …

OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance - Publication of Circular for Combined Annual General Meeting of September 30, 2025
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance Publication of Circular for Combined Annual General Meeting of September 30, 2025 Nantes, September 9, 2025, 8:30 p.m. CET - OSE Immunotherapeutics SA (ISIN: …

Le Conseil d’Administration appelle à soutenir une stratégie créatrice de valeur et une gouvernance ouverte - Publication des documents de convocation à l’Assemblée Générale Mixte du 30 septembre 2025
Le Conseil d’Administration appelle à soutenir une stratégie créatrice de valeur et une gouvernance ouverte Publication des documents de convocation à l’Assemblée Générale Mixte du 30 septembre 2025 NANTES, France – 9 septembre 2025, 20 heures 30 – OSE …

Booking Health Expands Access to Dendritic Cell Therapy After Study Confirms Survival Benefit in Glioblastoma Patients
Langenfeld, Germany, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Booking Health, a global medical travel platform, announced today the expansion of patient access to dendritic cell immunotherapy for recurrent glioblastoma, following the publication of new clinical …

Leptomeningeal Metastases Market to Exhibit Growth at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight
New York, USA, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Leptomeningeal Metastases Market to Exhibit Growth at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight The leptomeningeal metastases market is projected to grow steadily due to …

Del Bigtree and ICAN Announce Senate Hearing on Science and Corruption, Featuring Groundbreaking Study and Announces Documentary, "An Inconvenient Study"
WASHINGTON, DC, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Informed Consent Action Network (ICAN), led by Emmy Award-winning producer and veteran medical journalist Del Bigtree, today calls attention to a crucial hearing of the U.S. Senate Permanent …

Acesis Biomed Appoints Dr. Frederic Fasano, Pharm.D, MBA, ICD.D to the Board of Directors as Chairman
CENTENNIAL, Colo., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Acesis Holdings Corporation (“Acesis Biomed”), a pre‑clinical stage biotechnology company pioneering oral treatments for metabolic and endocrine disorders linked to low testosterone in men, today …

130+ Strategies for Resilient Rural Water and Sanitation Across the United States
Oakland, CA, USA, Sept. 09, 2025 (GLOBE NEWSWIRE) -- A new report released today by the Pacific Institute, a nonpartisan water think tank, outlines over 130 actionable strategies for rural communities across the United States to strengthen the climate …

Misophonia Research Fund to Host Impactful Conference on Misophonia: Bringing Together Science and Lived Experience to Create Solutions
CHICAGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- On September 18, 2025, Chicago will be the site of a groundbreaking gathering focused on one of the most misunderstood sensory conditions: misophonia, a disorder in which certain everyday sounds – like chewing, …

Chiesi Global Rare Diseases Highlights Continued Commitment to Rare Disease Community at the International Congress of Inborn Errors of Metabolism (ICIEM) 2025
Results presented focus on clinical insights on Fabry disease and alpha-mannosidosis Additional presentations showcase patient-reported journeys and outcomes PARMA, Italy, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of …

Chiesi Global Rare Diseases Highlights Continued Commitment to Rare Disease Community at the International Congress of Inborn Errors of Metabolism (ICIEM) 2025
Results presented focus on clinical insights on Fabry disease and alpha-mannosidosis Additional presentations showcase patient-reported journeys and outcomes PARMA, Italy, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of …

KFSHRC Deputy CEO at C3 Davos of Healthcare™ Summit: AI Will Support, Not Replace, Healthcare Workers
NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Artificial intelligence is ready to play a major role in healthcare, but it must be seen as a tool to empower medical staff, not replace them, according to Dr. Björn Zoëga, Deputy CEO of King Faisal Specialist …

SoldierStrong, Gier Productions Announce Release of “The Heroism and Resiliency of 9/11” Documentary in 2026
STAMFORD, Conn., Sept. 09, 2025 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit founded to help military veterans take their next steps forward in life, and award-winning director and producer Michael Gier today announced plans for the 2026 release …

SoCalBio Investor Conference Kicks Off October 1st with Keynote by SetPoint Medical CEO
LOS ANGELES, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Southern California Biomedical Council (SoCalBio) today announced the agenda, speakers, and presenting companies for its 27th Annual Investor …